May 7, 2020 / 10:00 PM / 21 days ago

Generic drugmaker Apotex admits fixing prices, to pay $24.1 million

Generic drugmaker Apotex Corp has agreed to pay $24.1 million and admit it conspired with other companies to artificially raise cholesterol drug’s price in the latest case to emerge from a U.S. Justice Department probe of price-fixing in the industry.

The Justice Department on Thursday announced that Apotex Corp had agreed to a deferred prosecution agreement to resolve the investigation. It is the fourth generic drug manufacturer to face charges in the wide-ranging antitrust investigation.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below